Item 16. Form 10-K Summary.
6K characters. Original on sec.gov · Markdown
Item 16. Form 10-K Summary.
None.
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on December 9, 2022.
THE COOPER COMPANIES, INC.
By: /s/ Albert G. White, III
Albert G. White, III
President & Chief Executive Officer
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on the dates set forth opposite their respective names.
| Signature | Capacity | Date | ||||||||||||
| /s/ ALBERT G. WHITE, III | President, Chief Executive Officer and Director (Principal Executive Officer) | December 9, 2022 | ||||||||||||
| (Albert G. White, III) | ||||||||||||||
| /s/ ROBERT S. WEISS | Chairman of the Board | December 9, 2022 | ||||||||||||
| (Robert S. Weiss) | ||||||||||||||
| /s/ WILLIAM A. KOZY | Vice Chairman of the Board and Lead Director | December 9, 2022 | ||||||||||||
| (William A. Kozy) | ||||||||||||||
| /s/ BRIAN G. ANDREWS | Executive Vice President, Chief Financial Officer and Treasurer | December 9, 2022 | ||||||||||||
| (Brian G. Andrews) | (Principal Financial Officer) | |||||||||||||
| /s/ AGOSTINO RICUPATI | Senior Vice President and Chief Accounting Officer | December 9, 2022 | ||||||||||||
| (Agostino Ricupati) | (Principal Accounting Officer) | |||||||||||||
| /s/ COLLEEN E. JAY | Director | December 9, 2022 | ||||||||||||
| (Colleen E. Jay) | ||||||||||||||
| /s/ JODY S. LINDELL | Director | December 9, 2022 | ||||||||||||
| (Jody S. Lindell) | ||||||||||||||
| /s/ GARY S. PETERSMEYER | Director | December 9, 2022 | ||||||||||||
| (Gary S. Petersmeyer) | ||||||||||||||
| /s/ MARIA RIVAS M.D. | Director | December 9, 2022 | ||||||||||||
| (Maria Rivas M.D.) | ||||||||||||||
| /s/ TERESA S. MADDEN | Director | December 9, 2022 | ||||||||||||
| (Teresa S. Madden) | ||||||||||||||
| /s/ CYNTHIA L. LUCCHESE | Director | December 9, 2022 | ||||||||||||
| (Cynthia L. Lucchese) |
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
CORPORATE INFORMATION
| BOARD OF DIRECTORS Robert S. Weiss Chairman of the Board William A. Kozy Vice Chairman and Lead Director Colleen E. Jay Director Jody S. Lindell President and Chief Executive Officer, S.G. Management, Inc. Cynthia L. Lucchese Chief Strategy Officer, Penske Entertainment Corp. Teresa S. Madden Director Gary S. Petersmeyer Director Maria Rivas M.D. Global Chief Medical Affairs Officer and Head of Evidence Generation, Pfizer, Inc. Albert G. White, III President & Chief Executive Officer COMMITTEES OF THE BOARD Audit Committee Teresa S. Madden (Chairman) Jody S. Lindell Cynthia L. Lucchese Gary S. Petersmeyer Maria Rivas M.D. Corporate Governance and Nominating Committee William A. Kozy (Chairman) Colleen E. Jay Jody S. Lindell Cynthia L. Lucchese Maria Rivas M.D. Organization and Compensation Committee Colleen E. Jay (Chairman) William A. Kozy Teresa S. Madden Gary S. Petersmeyer | EXECUTIVE OFFICERS Albert G. White, III President and Chief Executive Officer Daniel G. McBride Executive Vice President and Chief Operating Officer Brian G. Andrews Executive Vice President, Chief Financial Officer and Treasurer Agostino Ricupati Senior Vice President and Chief Accounting Officer Nicholas S. Khadder Vice President, General Counsel and Corporate Secretary Holly R. Sheffield President of CooperSurgical, Inc. Gerard H. Warner III President of CooperVision, Inc. PRINCIPAL SUBSIDIARIES CooperVision, Inc. 6101 Bollinger Canyon Road Suite 500 San Ramon, CA 94583 925-460-3600 www.coopervision.com CooperSurgical, Inc. 75 Corporate Drive Trumbull, CT 06611 203-601-5200 www.coopersurgical.com CORPORATE OFFICES The Cooper Companies, Inc. 6101 Bollinger Canyon Road Suite 500 San Ramon, CA 94583 925-460-3600 www.coopercos.com | INVESTOR INFORMATION Recent news releases, the annual report on Securities and Exchange Commission Form 10-K, information about the Company's corporate governance program, recent investor presentations, replays of quarterly conference calls and historical stock quotes are available on our Web site at www.coopercos.com. INVESTOR RELATIONS CONTACT Kim Duncan Vice President, Investor Relations and Risk Management 6101 Bollinger Canyon Road Suite 500 San Ramon, CA 94583 Voice: 925-460-3663 E-mail: ir@cooperco.com ANNUAL MEETING The Cooper Companies will hold its Annual Stockholders' Meeting in March 2023. TRANSFER AGENT American Stock Transfer & Trust Company 6201 15th Avenue Brooklyn, NY 11219 800-937-5449 TRADEMARKS The Cooper Companies, Inc., its subsidiaries or affiliates own, license or distribute the registered trademarks, common law trademarks and trade names referenced in this report. INDEPENDENT AUDITORS KPMG LLP STOCK EXCHANGE LISTING The New York Stock Exchange Ticker Symbol “COO” |
Previous: Item 15. Exhibits and Financial Statement Schedules.